NS4B inhibitors (PTC Therapeutics/Merck Research Laboratories)

N/A

Report date: 2025/06/11 10:58:58
NME

Base Information

Drug NameNS4B inhibitors (PTC Therapeutics/Merck Research Laboratories)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionNonstructural protein 4B inhibitors
TargetsNonstructural protein 4B
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics IncMerck Research Laboratories
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A